GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » EV-to-FCF

Healthlead PCL (BKK:HL) EV-to-FCF : 323.34 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Healthlead PCL's Enterprise Value is ฿2,713 Mil. Healthlead PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ฿8 Mil. Therefore, Healthlead PCL's EV-to-FCF for today is 323.34.

The historical rank and industry rank for Healthlead PCL's EV-to-FCF or its related term are showing as below:

BKK:HL' s EV-to-FCF Range Over the Past 10 Years
Min: -13966.62   Med: 135.98   Max: 414.5
Current: 329.82

During the past 5 years, the highest EV-to-FCF of Healthlead PCL was 414.50. The lowest was -13966.62. And the median was 135.98.

BKK:HL's EV-to-FCF is ranked worse than
95.16% of 62 companies
in the Medical Distribution industry
Industry Median: 20.595 vs BKK:HL: 329.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Healthlead PCL's stock price is ฿11.20. Healthlead PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ฿0.270. Therefore, Healthlead PCL's PE Ratio for today is 41.48.


Healthlead PCL EV-to-FCF Historical Data

The historical data trend for Healthlead PCL's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL EV-to-FCF Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - 61.56 399.49 297.40

Healthlead PCL Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 399.49 438.50 -13,966.62 -392.20 297.40

Competitive Comparison of Healthlead PCL's EV-to-FCF

For the Medical Distribution subindustry, Healthlead PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Healthlead PCL's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's EV-to-FCF falls into.



Healthlead PCL EV-to-FCF Calculation

Healthlead PCL's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2712.824/8.39
=323.34

Healthlead PCL's current Enterprise Value is ฿2,713 Mil.
Healthlead PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthlead PCL  (BKK:HL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Healthlead PCL's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.20/0.270
=41.48

Healthlead PCL's share price for today is ฿11.20.
Healthlead PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.270.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Healthlead PCL EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthlead PCL (BKK:HL) Business Description

Traded in Other Exchanges
N/A
Address
99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.